| 291 |
Long non-coding RNAs deregulated in Multiple Myeloma impact therapeutic response to proteasome inhibitors |
2015 |
| 292 |
Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) as Non-Invasive Biomarkers of Remodelling in Asthma |
2015 |
| 293 |
Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) as Non-Invasive Biomarkers of Remodelling in Asthma |
2015 |
| 294 |
Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) as Non-Invasive Biomarkers of Remodelling in Asthma |
2015 |
| 295 |
Matrix Metalloproteinase-9 (MMP-9) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) as Non-Invasive Biomarkers of Remodelling in Asthma |
2015 |
| 296 |
Metformin suppresses GRP78-dependent PI3-Kinase activity in clonogenic side population to enhance the anti-myeloma benefit of bortezomib |
2015 |
| 297 |
Methylated gene p15 and APC gene As biomarkers in Detection of HCC Versus MRI Diffusion In Cirrhotic Patients
|
2015 |
| 298 |
Methylated gene p15 and APC gene As biomarkers in Detection of HCC Versus MRI Diffusion In Cirrhotic Patients
|
2015 |
| 299 |
Methylated gene p15 and APC gene As biomarkers in Detection of HCC Versus MRI Diffusion In Cirrhotic Patients
|
2015 |
| 300 |
Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma |
2015 |